Home > Healthcare > Medical Devices > Diagnostic Devices > Rabies Diagnostics Market

Rabies Diagnostics Market Share

Report ID: GMI10186
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Rabies Diagnostics Market Share

The global market is characterized by a competitive landscape driven by advancements in diagnostic technologies, increasing investment in research and development, and a focus on early disease detection. The development and launch of novel products with improved efficiency and cost-effectiveness are key market strategies for rabies diagnostics product manufacturers, driving competition and innovation in the industry. The market is further intensified by the presence of regional players who cater to local demands and regulatory requirements. Collaborations between veterinary organizations, government bodies, and diagnostic companies are pivotal in promoting widespread adoption of rabies diagnostics, thereby driving market growth.

Rabies Diagnostics Market Companies

Some of the eminent market participants operating in the rabies diagnostics industry include:

Abbexa Ltd
Aviva Systems Biology Corporation
BIONOTE Co., LTD
Bio-Rad Laboratories, Inc.
Creative Diagnostics
Demeditec Diagnostics GmbH
Merck KGaA
MyBioSource, Inc.
Norgen Biotek Corp.
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Rabies diagnostics industry size was USD 1.8 billion in 2023 and is projected to expand at 4.7% CAGR from 2024 to 2032, due to the rising cases of animal bites, coupled with favorable government policies.

The fluorescent antibody test (FAT) segment in the rabies diagnostics industry accounted for USD 503.1 million in 2023 and is estimated to grow at significant CAGR from 2024 to 2032, owing to its reliability, accuracy, and long history of use.

The ELISA technology segment in the rabies diagnostics industry is projected to record USD 911.3 million by 2032, due to their high sensitivity and specificity in detecting antibodies or antigens related to the rabies virus.

North America rabies diagnostics industry amassed USD 765.8 million in revenue in 2023 and is projected to depict substantial gains from 2024 to 2032, led by the growing prevalence of rabies in the region.